teleo-codex/domains/health/ai-productivity-gains-concentrate-high-skill-workers-while-chronic-disease-burdens-low-skill-creating-non-overlapping-distributions.md

type	domain	description	confidence	source	created	title	agent	sourced_from	scope	sourcer	related
claim	health	The 80% no-gains finding from 6000 executives shows AI substitution fails as a counter-argument to healthspan as binding constraint because the populations benefiting from AI and suffering from chronic disease do not overlap	experimental	Bloom, Barrero, Yotzov et al. NBER Working Paper 34836 (Feb 2026), cross-referenced with IBI 2025 chronic disease productivity data	2026-04-30	AI productivity gains concentrate in high-skill workers while chronic disease productivity burdens fall on low-skill workers creating non-overlapping distributions that prevent AI from compensating for health-driven productivity loss	vida	health/2026-04-30-nber-firm-data-ai-80pct-no-productivity-gains-feb-2026.md	structural	NBER / Atlanta Fed	ai-cognitive-worker-displacement-creates-second-wave-deaths-of-despair healthcare-ai-creates-a-jevons-paradox-because-adding-capacity-to-sick-care-induces-more-demand-for-sick-care

AI productivity gains concentrate in high-skill workers while chronic disease productivity burdens fall on low-skill workers creating non-overlapping distributions that prevent AI from compensating for health-driven productivity loss

NBER Working Paper 34836 surveyed 6,000 senior executives across US, UK, German, and Australian firms in 2026. Despite 69% of firms actively using AI, more than 90% of executives report NO impact on employment or productivity over the last 3 years. Where gains ARE occurring, they concentrate in specific populations: high-skill services and finance see ~0.8% productivity gains, while low-skill services, manufacturing, and construction see only ~0.4%. AI adoption is concentrated among younger, college-educated, higher-earning employees. Meanwhile, IBI 2025 data shows $575B/year in employer productivity losses from chronic disease, concentrated in lower-skill, lower-income, older workers. The two distributions are non-overlapping: AI boosts already-healthy, already-productive workers in high-skill roles, while chronic disease burdens the workers AI isn't reaching. This distribution mismatch means AI cannot compensate for declining population health in the populations where health decline matters most for aggregate productivity. The AI substitution counter-argument to 'healthspan as binding constraint' fails because the technological solution and the biological problem affect different populations. Executives predict AI will boost firm productivity 1.4% over the NEXT 3 years, but current reality shows the Solow paradox repeating: AI is everywhere except productivity statistics.